CPRRX | CPXCX | CPRRX / CPXCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 15 years | - |
Gain YTD | 10.045 | 9.507 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.89B | 7.89B | 100% |
Annual Yield % from dividends | 5.20 | 4.76 | 109% |
Returns for 1 year | 15.26 | 14.65 | 104% |
Returns for 3 years | 1.32 | -0.19 | -700% |
Returns for 5 years | 11.98 | 9.12 | 131% |
Returns for 10 years | 48.82 | 41.60 | 117% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNVMX | 14.67 | 0.02 | +0.14% |
JPMorgan Developed International ValueR6 | |||
BCEGX | 28.01 | -0.24 | -0.85% |
Sterling Capital Equity Income C | |||
GCGVX | 20.66 | -0.26 | -1.24% |
Goldman Sachs U.S. Equity ESG C | |||
POIRX | 15.46 | -0.21 | -1.34% |
Polen International Growth Investor | |||
BHSRX | 64.71 | -1.57 | -2.37% |
BlackRock Health Sciences Opps R |